Impact of HDAC inhibitors on macrophage polarization to enhance innate immunity against infections

Drug Discov Today. 2024 Nov;29(11):104193. doi: 10.1016/j.drudis.2024.104193. Epub 2024 Sep 26.

Abstract

Innate immunity plays an important role in host defense against pathogenic infections. It involves macrophage polarization into either the pro-inflammatory M1 or the anti-inflammatory M2 phenotype, influencing immune stimulation or suppression, respectively. Epigenetic changes during immune reactions contribute to long-term innate immunity imprinting on macrophage polarization. It is becoming increasingly evident that epigenetic modulators, such as histone deacetylase (HDAC) inhibitors (HDACi), enable the enhancement of innate immunity by tailoring macrophage polarization in response to immune stressors. In this review, we summarize current literature on the impact of HDACi and other epigenetic modulators on the functioning of macrophages during diseases that have a strong immune component, such as infections. Depending on the disease context and the chosen therapeutic intervention, HDAC1, HDAC2, HDAC3, HDAC6, or HDAC8 are particularly important in influencing macrophage polarization towards either M1 or M2 phenotypes. We anticipate that therapeutic strategies based on HDAC epigenetic mechanisms will provide a unique approach to boost immunity against disease challenges, including resistant infections.

Keywords: HDAC; Infections; Inflammation; Innate immunity; Macrophage polarization.

Publication types

  • Review

MeSH terms

  • Animals
  • Epigenesis, Genetic* / drug effects
  • Histone Deacetylase Inhibitors* / pharmacology
  • Histone Deacetylases / metabolism
  • Humans
  • Immunity, Innate* / drug effects
  • Infections / drug therapy
  • Infections / immunology
  • Macrophages* / drug effects
  • Macrophages* / immunology

Substances

  • Histone Deacetylase Inhibitors
  • Histone Deacetylases